gabbo

  Chinook Therapeutics
  Element AI
  Repare Therapeutics
  Enerkem
  DalCor Pharmaceuticals
  Verafin
  Fusion Pharmaceuticals
  Stormfiser Biogas
  Hootsuite
  North

  Despite investing the second most into venture capital amongst all OECD countries, Canada is producing the least amount of unicorns. Not only that, of the unicorns it produces, valuation are also the lowest amongst the group (to be fair, the sample size is tiny. Plus, Canada’s unicorns are generally really new compared to that of other countries, which may have opted to stay private for a variety of reasons). For an ecosystem that is by most metrics, really well funded and really strong, the number of narwhals and unicorns that it produces is disappointing. In terms of creating billion dollars startups, Canada is ruthlessly inefficient compared to the likes of Germany, Sweden and the United Kingdom.